Informationen:
Fehler:
ID
31397
Beschreibung
Vildagliptin in New Onset Diabetes After Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT00980356
Link
https://clinicaltrials.gov/show/NCT00980356
Stichworte
Versionen (1)
- 19.08.18 19.08.18 -
Rechteinhaber
see clinicaltrials.gov
Hochgeladen am
19. August 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Diabetes Mellitus NCT00980356
Eligibility Diabetes Mellitus NCT00980356
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Diabetes Mellitus NCT00980356
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
New Onset Diabetes After Transplant; Glucose tolerance test; Pathologic
Item
• newly diagnosed nodat defined by pathologic ogtt (2h, 75mg glucose): glucose ≥ 200mg/dl
boolean
C3896643 (UMLS CUI [1,1])
C0017741 (UMLS CUI [1,2])
C1521733 (UMLS CUI [1,3])
C0017741 (UMLS CUI [1,2])
C1521733 (UMLS CUI [1,3])
Kidney Transplantation; Cadaver donor (person); Living Donors | Immunosuppression | Tacrolimus | Cyclosporine | mycophenolate mofetil | Azathioprine | Prednisone
Item
renal transplantation (deceased or living donor) and treatment with the standard immunosuppression at our center, consisting of triple therapy with tacrolimus or cyclosporine a, mycophenolate mofetil or azathioprine, and prednisone.
boolean
C0022671 (UMLS CUI [1,1])
C0524354 (UMLS CUI [1,2])
C0348050 (UMLS CUI [1,3])
C4048329 (UMLS CUI [2])
C0085149 (UMLS CUI [3])
C0010592 (UMLS CUI [4])
C0209368 (UMLS CUI [5])
C0004482 (UMLS CUI [6])
C0032952 (UMLS CUI [7])
C0524354 (UMLS CUI [1,2])
C0348050 (UMLS CUI [1,3])
C4048329 (UMLS CUI [2])
C0085149 (UMLS CUI [3])
C0010592 (UMLS CUI [4])
C0209368 (UMLS CUI [5])
C0004482 (UMLS CUI [6])
C0032952 (UMLS CUI [7])
Graft material; Stable status; Duration (temporal concept)
Item
stable graft function for more than 6 months post transplant.
boolean
C0181074 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Informed Consent
Item
informed consent of the patient
boolean
C0021430 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent
Item
patients with prior history of type 1 or type 2 diabetes
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C0011860 (UMLS CUI [2])
Body mass index
Item
body mass index (bmi) > 40
boolean
C1305855 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Renal Insufficiency; Severe (severity modifier)
Item
severe renal impairment (gfr < 30 ml/min./1.73 m2)
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Hepatic impairment; Severe (severity modifier)
Item
severe liver impairment
boolean
C0948807 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Plasma Glucose Measurement; Elevation; Severe (severity modifier)
Item
severe blood glucose elevation with the need for therapy with insulin or hba1c >8.5%
boolean
C0202042 (UMLS CUI [1,1])
C0702240 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C0702240 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])